FDA Expands Disqualification of Clinical Investigators for Research and Marketing Permits

Summary

The FDA is amending its regulations to broaden the scope of disqualification for clinical investigators, making them ineligible for other types of products regulated by the agency, in an effort to protect research subjects and data integrity.